News

Dunad Therapeutics emerges to develop next-generation small molecule therapeutics based on its highly differentiated, tuneable and targeted protein degradation technology. Dunad secured…
Read More...

Pfizer Inc. announced that it is progressing to multiple ascending doses after completing the dosing of single ascending doses in a Phase 1 study in healthy adults to evaluate the…
Read More...

Sanofi has concluded an agreement to divest an integrated portfolio of its anti-inflammatory drugs to Fidia Farmaceutici, a privately-held company headquartered in Italy. This…
Read More...

In response to ongoing developments throughout the pandemic, NICE has produced numerous rapid COVID-19 guidelines to help healthcare workers respond to the ongoing pandemic. Feedback…
Read More...

Cipla Therapeutics, an affiliate of Cipla Limited and SIGA Technologies, Inc. (SIGA) a commercial-stage pharmaceutical company focused on the health security market announced entering…
Read More...

SemaThera Inc. announced the signing of a multi-year research collaboration and licensing agreement with Roche. The partnership will focus on developing SemaThera’s promising new class…
Read More...

RELIEF THERAPEUTICS Holding AG, a biopharmaceutical company with its lead compound RLF-100™ (aviptadil) in advanced clinical development to treat severe COVID-19 patients, and Acer…
Read More...

BioAge Labs, Inc., a clinical-stage biotechnology company developing medications that target aging to treat severe diseases, announced that it has commenced a Phase 2 clinical trial of…
Read More...

EMA has reviewed the latest evidence on the use of ivermectin for the prevention and treatment of COVID-19 and concluded that the available data do not support its use for COVID-19…
Read More...

Komodo Health announced a $220 million Series E funding round led by Tiger Global Management and joined by Casdin Capital. Existing investors ICONIQ Growth, Andreessen Horowitz, and SVB…
Read More...

The AstraZeneca US Phase III trial of AZD1222 demonstrated statistically significant vaccine efficacy of 79% at preventing symptomatic COVID-19 and 100% efficacy at preventing severe…
Read More...

Everest Medicines, a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products that address critical unmet medical needs for patients in…
Read More...

Indivumed GmbH announced the founding of Ix Therapeutics GmbH, a joint venture with Xlife Sciences AG, which marks Indivumed's expansion into target discovery and early cancer drug…
Read More...

The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the U.S. Food and Drug Administration (FDA) approved PONVORY (ponesimod), a once-daily oral selective…
Read More...

Oramed Pharmaceuticals Inc. a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced that it has entered into definitive agreements to…
Read More...

Pyxis Oncology announced that it has entered into a worldwide license agreement with Pfizer Inc. for the development and commercialization of two antibody-drug conjugate (ADC)…
Read More...

Boston Pharmaceuticals announced a pioneering three-year out-license and option agreement with GlaxoSmithKline PLC. Boston Pharmaceuticals will become a preferred GSK partner for select…
Read More...

Today the Medicines Health Regulatory Authority (MHRA) and European Medicines Agency (EMA) reaffirmed the benefits of COVID-19 Vaccine AstraZeneca continue to far outweigh the risks.…
Read More...

Ambrx, a clinical stage biopharmaceutical company using an expanded genetic code to create Engineered Precision Biologics, announced that the U.S. Food and Drug Administration (FDA) has…
Read More...

Valence Discovery an emerging leader in AI-enabled drug design, announced it has entered into a drug discovery agreement with Repare Therapeutics, a precision oncology company…
Read More...